Joseph on for Mike Matson's questions to ICU Medical Inc (ICUI) leadership • Q4 2024
Question
Joseph, on for Mike Matson, requested a breakdown of the drivers for the 2025 Consumables guidance and asked about the key factors needed to achieve the company's long-term $500 million EBITDA target.
Answer
Executive Brian Bonnell noted that for 2025 Consumables growth, all product lines are expected to contribute, with particular confidence in the legacy ICU lines of core infusion and oncology. Executive Vivek Jain outlined that reaching the $500M EBITDA goal depends on three main drivers: sustained revenue growth fueled by innovation, gross margin expansion from pricing and operational synergies, and a potential tailwind from favorable currency movements.